They're FDA-approved
OA-causing factors such as age and mechanical stress lead to excessive oxidative stress in chondrocytes 37,38
Clinical data shows palpitations occur in approximately 5-8% of GLP-1 users, often during dose escalation or in individuals with underlying cardiac sensitivity
Adjust your supply calculations accordingly
The post-discontinuation phase remains the least investigated, although extension studies consistently show that weight regain occurs rapidly, with patients regaining up to two-thirds of the lost weight within one year after withdrawal ( As the field evolves, questions remain about whether the future of obesity and diabetes management will prioritize pharmacotherapy, lifestyle, or a hybrid approach, especially given the challenges of long-term adherence and the broader health impacts of lifestyle change ( This narrative review synthesizes current evidence on GLP-1RAs, including both conventional single-agent therapies and dual GIP/GLP-1 receptor agonists, versus exercise, their combined effects, and the implications for future clinical and public health priorities
An Fc receptor structurally related to MHC class I antigens